Ignite Creation Date:
2025-12-25 @ 4:02 AM
Ignite Modification Date:
2026-03-03 @ 4:34 AM
Study NCT ID:
NCT03755102
Status:
COMPLETED
Last Update Posted:
2025-05-15
First Post:
2018-11-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Pilot Study of Dacomitinib With or Without Osimertinib for Patients With Metastatic EGFR Mutant Lung Cancers With Disease Progression on Osimertinib.
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-11-21
Start Date Type:
ACTUAL
Primary Completion Date:
2023-07-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-07-07
Completion Date Type:
ACTUAL
First Submit Date:
2018-11-26
First Submit QC Date:
None
Study First Post Date:
2018-11-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-05-12
Last Update Post Date:
2025-05-15
Last Update Post Date Type:
ACTUAL